Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression

International Clinical Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 55-57

  Otani, K ^a   Yasui, N ^a   Kaneko, S ^a   Ohkubo, T ^a   Osanai, T ^b   Sugawara, K ^a  

^a HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^b Goshogawara City Hospital   (Japan)

Author keywords

augmentation therapy; carbamazepine; refractory depression; serotonin; trazodone

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CARBAMAZEPINE; DRUG METABOLITE; TRAZODONE;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0029925954     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199603000-00008     Document Type: Article

References (19)

1. Bertilsson L and Tomson T (1986) Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clinical Pharmacokinetics, 11, 177-198.
2. Bertilsson L, Mellstrom B and Sjoqvist F (1979) Pronounced inhibition of noradrenaline uptake by 10-hydroxy-metabolites of nortriptyline. Life Sciences, 25, 1285-1292.
3. Brosen K and Kragh-Sorensen P (1993) Concomitant intake of nortriptyline and carbamazepine. Therapeutic Drug Monitoring, 15, 258-260.
4. De la Fuente JM and Mendlewicz J (1992) Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression. Biological Psychiatry, 32, 369-374.
5. Extein IL and Gold MS (1989) Thyroid hormone potentiation of tricyclic antidepressants. In: Treatment of Tricyclic-Resistant Depression (Ed. IL Extein), pp. 27-48. American Psychiatric Press, Washington, DC.
6. Ishida M, Otani K, Kaneko S, Ohkubo T, Osanai T, Yasui N. Mihara K, Higuchi H, Sugawara K and Fukushima Y (1995) Effects of various factors on steady-state plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine. International Clinical Psychopharmacology, in press.
7. Kahn RS and Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biological Psychiatry, 30, 1139-1166.
8. Kaneko S, Okada M, Hirano T, Kondo T, Otani K and Fukushima Y (1993) Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Japanese Journal of Psychiatry and Neurology, 47, 371-373.
9. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ and Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica, 76(Suppl), 334.
10. Marek GJ, McDougle CJ, Price LH and Seiden LS (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology, 109, 2-11.
11. Mayol RF, Cole CA, Colson KE and Kerns EH (1994) Isolation and identification of the major urinary metabolite of m-chlorophenylpiperazine in the rat. Drug Metabolism and Disposition, 22, 171-174.
12. Mizuno K, Okada M, Kaneko S, Hirano T, Tokinaga N, Chiba T, Otani K and Fukushima Y (1994) Effects of zonisamide, carbamazepine and valproate on monoamine metabolism in rat striatum and hippocampus. Japanese Journal of Psychiatry and Neurology, 48, 406-408.
13. Montgomery SA and Asberg M (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
14. Ohkubo T, Osanai T, Sugawara K, Ishida M, Otani K, Mihara K and Yasui N (1995) High-performance liquid chromatographic determination of trazodone and 1-m-chlorophenylpiperazine with ultraviolet and electrochemical detector. Journal of Pharmacy and Pharmacology, 47, 340-344.
15. Otani K, Kaneko S, Sasa H, Kondo T and Fukushima Y (1991) Is there a therapeutic window for plasma concentration of mianserin plus desmethylmianserin? Human Psychopharmacology, 6, 243-248.
16. Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, Marangell L and George MS (1994) Anticonvulsants in refractory mood disorders. In: Refractory Depression: Current Strategies and Future Directions (Eds WA Nolen et al.), pp. 97-114. John Wiley & Sons, Chichester.
17. Price LH (1989) Lithium augmentation in tricyclic-resistant depression. In: Treatment of Tricyclic-Resistant Depression (Ed. IL Extein), pp. 49-79. American Psychiatric Press, Washington, DC.
18. Riblet LA and Taylor DP (1981) Pharmacology and neurochemistry of trazodone. Journal of Clinical Psychopharmacology, 1 (suppl), 17S-22S.
19. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ and Soloff PH (1985) The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430-436.